Skip to content
healthcare.dev

PANCREAZE

NDC 62541-406, PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE, capsule, delayed release, from VIVUS LLC.

Product NDC
62541-406
Status
Listed
Labeler
VIVUS LLC
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022523
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62541-406 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PANCRELIPASE LIPASE37000 [USP'U]/1
  • PANCRELIPASE AMYLASE149900 [USP'U]/1
  • PANCRELIPASE PROTEASE97300 [USP'U]/1
Package NDCNDC-11Package
62541-406-10625410406102 BOTTLE, GLASS in 1 CARTON (62541-406-10) / 50 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS (62541-406-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e8f5d2fe-728d-42af-99a6-83dddc6539c5

Use it

Look up 62541-406 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62541-406 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62541-406. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.